User profiles for P. Fritz
Patrick W. FritzPhD Student, University of Fribourg Verified email at unifr.ch Cited by 181 |
The health effects of nonindustrial indoor air pollution
…, N Alexis, H Bacchus, IL Bernstein, P Fritz… - Journal of Allergy and …, 2008 - Elsevier
BACKGROUND: There is growing public awareness regarding the risk associated with poor
indoor air quality in the home and workplace. Because Americans spend approximately 22 …
indoor air quality in the home and workplace. Because Americans spend approximately 22 …
[HTML][HTML] Porous organic polymers for CO 2 capture, separation and conversion
… Fritz obtained his BSc in technical chemistry from Technische Universität Wien (TU Wien)
in 2018 and received his MSc from the institute of materials chemistry and the institute of …
in 2018 and received his MSc from the institute of materials chemistry and the institute of …
A work group report on ultrafine particles (American Academy of Allergy, Asthma & Immunology): Why ambient ultrafine and engineered nanoparticles should receive …
… a similar association was also found between ischemic heart disease mortality and PM 2.5
, statistical analysis showed that UFP mass and its constituents had a better fit and a lower P …
, statistical analysis showed that UFP mass and its constituents had a better fit and a lower P …
[BOOK][B] Environmental isotopes in hydrogeology
ID Clark, P Fritz - 2013 - taylorfrancis.com
… There, the potential for tracing the origin of the thermal waters with environmental isotopes
began a long and fruitful collaboration with Peter Fritz, then a professor at Waterloo. Following …
began a long and fruitful collaboration with Peter Fritz, then a professor at Waterloo. Following …
NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression
…, M Schlee, KR Herrlinger, A Stallmach, F Noack, P Fritz… - Gut, 2004 - gut.bmj.com
Background: Mutations in NOD2, a putative intracellular receptor for bacterial peptidoglycans,
are associated with a subset of Crohn’s disease but the molecular mechanism linking this …
are associated with a subset of Crohn’s disease but the molecular mechanism linking this …
Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology
…, G Meinhardt, A Athanasiadis, H Vogelsberg, P Fritz… - Circulation, 2004 - Am Heart Assoc
Background— Myocarditis can occasionally lead to sudden death and may progress to dilated
cardiomyopathy in up to 10% of patients. Because the initial onset is difficult to recognize …
cardiomyopathy in up to 10% of patients. Because the initial onset is difficult to recognize …
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors
…, W Schroth, H Brauch, M Schwab, P Fritz… - Clinical Cancer …, 2011 - AACR
Purpose: According to current guidelines, molecular tests predicting the outcome of breast
cancer patients can be used to assist in making treatment decisions after consideration of …
cancer patients can be used to assist in making treatment decisions after consideration of …
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis
…, S Hager, G Meinhardt, H Vogelsberg, P Fritz… - Circulation, 2006 - Am Heart Assoc
… Significant differences in LVEF at initial CMR were detected between the PVB19 and
HHV6 groups (P=0.03/P adj =0.03) as well as between the PVB19 and combined PVB19/HHV6 …
HHV6 groups (P=0.03/P adj =0.03) as well as between the PVB19 and combined PVB19/HHV6 …
Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis
BK Abraham, P Fritz, M McClellan, P Hauptvogel… - Clinical cancer …, 2005 - AACR
… All P values resulted from two-sided tests and were considered significant when <0.05. …
cells, 12 cases (80%) had distant metastasis only (P = 0.04). All 5 cases with more than 20% …
cells, 12 cases (80%) had distant metastasis only (P = 0.04). All 5 cases with more than 20% …
Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen
…, U Hamann, PA Fasching, M Schmidt, S Winter, P Fritz… - Jama, 2009 - jamanetwork.com
Context The growth inhibitory effect of tamoxifen, which is used for the treatment of hormone
receptor–positive breast cancer, is mediated by its metabolites, 4-hydroxytamoxifen and …
receptor–positive breast cancer, is mediated by its metabolites, 4-hydroxytamoxifen and …